• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOD1 调控 KRAS 突变型非小细胞肺癌的核糖体生物发生。

SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer.

机构信息

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.

Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.

出版信息

Nat Commun. 2021 Apr 15;12(1):2259. doi: 10.1038/s41467-021-22480-x.

DOI:10.1038/s41467-021-22480-x
PMID:33859191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8050259/
Abstract

SOD1 is known as the major cytoplasmic superoxide dismutase and an anticancer target. However, the role of SOD1 in cancer is not fully understood. Herein we describe the generation of an inducible Sod1 knockout in KRAS-driven NSCLC mouse model. Sod1 knockout markedly reduces tumor burden in vivo and blocks growth of KRAS mutant NSCLC cells in vitro. Intriguingly, SOD1 is enriched in the nucleus and notably in the nucleolus of NSCLC cells. The nuclear and nucleolar, not cytoplasmic, form of SOD1 is essential for lung cancer cell proliferation. Moreover, SOD1 interacts with PeBoW complex and controls its assembly necessary for pre-60S ribosomal subunit maturation. Mechanistically, SOD1 regulates co-localization of PeBoW with and processing of pre-rRNA, and maturation of cytoplasmic 60S ribosomal subunits in KRAS mutant lung cancer cells. Collectively, our study unravels a nuclear SOD1 function essential for ribosome biogenesis and proliferation in KRAS-driven lung cancer.

摘要

SOD1 被称为主要的细胞质超氧化物歧化酶和抗癌靶点。然而,SOD1 在癌症中的作用尚不完全清楚。在此,我们描述了在 KRAS 驱动的 NSCLC 小鼠模型中诱导型 Sod1 敲除的产生。Sod1 敲除显著减少体内肿瘤负担,并阻断 KRAS 突变型 NSCLC 细胞的体外生长。有趣的是,SOD1 在 NSCLC 细胞的核内富集,尤其是在核仁中。SOD1 的核内和核仁形式,而不是细胞质形式,对肺癌细胞增殖至关重要。此外,SOD1 与 PeBoW 复合物相互作用,并控制其组装,这对于 pre-60S 核糖体亚基成熟是必需的。在机制上,SOD1 调节 PeBoW 与 pre-rRNA 的共定位和处理,以及 KRAS 突变型肺癌细胞中细胞质 60S 核糖体亚基的成熟。总之,我们的研究揭示了核 SOD1 在 KRAS 驱动的肺癌中核糖体生物发生和增殖所必需的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/87078a0f9229/41467_2021_22480_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/3e89edd5b439/41467_2021_22480_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/015ef8eb1733/41467_2021_22480_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/3862ca909a3d/41467_2021_22480_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/9ece38b2fa03/41467_2021_22480_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/6f45350d01c6/41467_2021_22480_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/88c82f95464d/41467_2021_22480_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/87078a0f9229/41467_2021_22480_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/3e89edd5b439/41467_2021_22480_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/015ef8eb1733/41467_2021_22480_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/3862ca909a3d/41467_2021_22480_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/9ece38b2fa03/41467_2021_22480_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/6f45350d01c6/41467_2021_22480_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/88c82f95464d/41467_2021_22480_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ef/8050259/87078a0f9229/41467_2021_22480_Fig7_HTML.jpg

相似文献

1
SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer.SOD1 调控 KRAS 突变型非小细胞肺癌的核糖体生物发生。
Nat Commun. 2021 Apr 15;12(1):2259. doi: 10.1038/s41467-021-22480-x.
2
Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer.PIERCE1 缺失导致 AKT 信号受损并促进 KRAS 突变型非小细胞肺癌发生肿瘤。
Oncogene. 2020 Sep;39(36):5876-5887. doi: 10.1038/s41388-020-01399-5. Epub 2020 Jul 29.
3
Role of the yeast ribosomal protein L16 in ribosome biogenesis.酵母核糖体蛋白L16在核糖体生物合成中的作用。
FEBS J. 2016 Aug;283(16):2968-85. doi: 10.1111/febs.13797. Epub 2016 Jul 15.
4
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.XPO1 依赖的核输出是 KRAS 突变型肺癌中的一个可药物靶向的弱点。
Nature. 2016 Oct 6;538(7623):114-117. doi: 10.1038/nature19771. Epub 2016 Sep 28.
5
Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.BET 溴结构域抑制在 Kras 突变型非小细胞肺癌中的疗效。
Clin Cancer Res. 2013 Nov 15;19(22):6183-92. doi: 10.1158/1078-0432.CCR-12-3904. Epub 2013 Sep 17.
6
Principles of 60S ribosomal subunit assembly emerging from recent studies in yeast.源于近期酵母研究的60S核糖体亚基组装原理
Biochem J. 2017 Jan 15;474(2):195-214. doi: 10.1042/BCJ20160516.
7
RRP1B targets PP1 to mammalian cell nucleoli and is associated with Pre-60S ribosomal subunits.RRP1B 将 PP1 靶向哺乳动物细胞核仁,并与 Pre-60S 核糖体亚基相关联。
Mol Biol Cell. 2010 Dec;21(23):4212-26. doi: 10.1091/mbc.E10-04-0287. Epub 2010 Oct 6.
8
Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer.LKB1 突变增强了曲美替尼与放疗联用对 KRAS 突变型非小细胞肺癌的放射增敏作用。
Clin Cancer Res. 2018 Nov 15;24(22):5744-5756. doi: 10.1158/1078-0432.CCR-18-1489. Epub 2018 Aug 1.
9
Pol5 is an essential ribosome biogenesis factor required for 60S ribosomal subunit maturation in .Pol5 是核糖体生物发生所必需的一种因子,对于 在 60S 核糖体亚基成熟过程中是必需的。
RNA. 2019 Nov;25(11):1561-1575. doi: 10.1261/rna.072116.119. Epub 2019 Aug 14.
10
KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.唑来膦酸在人非小细胞癌临床前模型中的KRAS突变状态依赖性效应。
Oncotarget. 2016 Nov 29;7(48):79503-79514. doi: 10.18632/oncotarget.12806.

引用本文的文献

1
Ribosome biogenesis: A central player in liver diseases.核糖体生物发生:肝脏疾病中的核心因素。
Genes Dis. 2025 Jan 4;12(5):101512. doi: 10.1016/j.gendis.2025.101512. eCollection 2025 Sep.
2
Cuproptosis as a therapeutic target in cancer: a Systematic Review and bibliometric analysis of the research landscape.铜死亡作为癌症治疗靶点:研究现状的系统评价与文献计量分析
Front Oncol. 2025 May 16;15:1566986. doi: 10.3389/fonc.2025.1566986. eCollection 2025.
3
Copper metabolism in hepatocellular carcinoma: from molecular mechanisms to therapeutic opportunities.

本文引用的文献

1
SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation.SOD1 对于癌基因驱动的乳腺肿瘤形成是必需的,但对于正常发育和增殖是可有可无的。
Oncogene. 2019 Jul;38(29):5751-5765. doi: 10.1038/s41388-019-0839-x. Epub 2019 Jun 20.
2
Eukaryotic Ribosome Assembly.真核生物核糖体组装。
Annu Rev Biochem. 2019 Jun 20;88:281-306. doi: 10.1146/annurev-biochem-013118-110817. Epub 2018 Dec 19.
3
Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation.
肝细胞癌中的铜代谢:从分子机制到治疗机遇
Front Mol Biosci. 2025 May 13;12:1578693. doi: 10.3389/fmolb.2025.1578693. eCollection 2025.
4
Exploring ribosome biogenesis in lung adenocarcinoma to advance prognostic methods and immunotherapy strategies.探索肺腺癌中的核糖体生物合成以改进预后方法和免疫治疗策略。
J Transl Med. 2025 May 2;23(1):503. doi: 10.1186/s12967-025-06489-0.
5
Simple In-Cell Processing Enables Deep Proteome Analysis of Low-Input .简单的细胞内处理可实现低输入量的深度蛋白质组分析。
Anal Chem. 2025 May 6;97(17):9159-9167. doi: 10.1021/acs.analchem.4c05003. Epub 2025 Apr 21.
6
Increased Expression of Superoxide Dismutase 2 Is an Indicator of Worse Prognosis of Oropharyngeal Cancer.超氧化物歧化酶2表达增加是口咽癌预后较差的一个指标。
Int J Mol Sci. 2025 Mar 30;26(7):3223. doi: 10.3390/ijms26073223.
7
Cuproplasia and cuproptosis, two sides of the coin.铜代谢异常和铜死亡,一枚硬币的两面。
Cancer Commun (Lond). 2025 May;45(5):505-524. doi: 10.1002/cac2.70001. Epub 2025 Jan 25.
8
Facts, Dogmas, and Unknowns About Mitochondrial Reactive Oxygen Species in Cancer.关于癌症中线粒体活性氧的事实、教条与未知
Antioxidants (Basel). 2024 Dec 19;13(12):1563. doi: 10.3390/antiox13121563.
9
Cuproptosis: a promising new target for breast cancer therapy.铜死亡:乳腺癌治疗的一个有前景的新靶点。
Cancer Cell Int. 2024 Dec 19;24(1):414. doi: 10.1186/s12935-024-03572-2.
10
Selenoprotein O Promotes Melanoma Metastasis and Regulates Mitochondrial Complex II Activity.硒蛋白O促进黑色素瘤转移并调节线粒体复合物II活性。
Cancer Res. 2025 Mar 3;85(5):942-955. doi: 10.1158/0008-5472.CAN-23-2194.
鉴定WDR12作为一种参与肝细胞癌增殖的新型癌基因。
Cancer Manag Res. 2018 Sep 27;10:3985-3993. doi: 10.2147/CMAR.S176268. eCollection 2018.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.PES1 受 BRD4 转录调控,促进肝癌细胞增殖和糖酵解。
Int J Biochem Cell Biol. 2018 Nov;104:1-8. doi: 10.1016/j.biocel.2018.08.014. Epub 2018 Aug 29.
6
SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation.mTORC1 介导的 SOD1 磷酸化将营养感应与氧化还原调节偶联。
Mol Cell. 2018 May 3;70(3):502-515.e8. doi: 10.1016/j.molcel.2018.03.029.
7
Influence of estrogen in non-small cell lung cancer and its clinical implications.雌激素在非小细胞肺癌中的作用及其临床意义。
J Thorac Dis. 2018 Jan;10(1):482-497. doi: 10.21037/jtd.2017.12.61.
8
Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma.雄激素受体过表达及雄激素受体/雷帕霉素靶蛋白相互作用在肝细胞癌中的意义和机制。
Hepatology. 2018 Jun;67(6):2271-2286. doi: 10.1002/hep.29715. Epub 2018 Apr 20.
9
Ribosome biogenesis in cancer: new players and therapeutic avenues.癌症中的核糖体生物发生:新的参与者和治疗途径。
Nat Rev Cancer. 2018 Jan;18(1):51-63. doi: 10.1038/nrc.2017.104. Epub 2017 Dec 1.
10
Ribosomopathies: There's strength in numbers.核糖体病:众志成城。
Science. 2017 Nov 3;358(6363). doi: 10.1126/science.aan2755.